Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Lyon
Gholson J
GJ
D000328:Adult; D019969:Amphetamine-Related Disorders / Q000150:complications* / Q000523:psychology / Q000534:rehabilitation; D001552:Benzazepines / Q000009:adverse effects*; D001883:Borderline Personality Disorder / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D003865:Major Depressive Disorder / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D054333:Drug Partial Agonism; D005260:Female; D006801:Humans; D007508:Irritable Mood / Q000187:drug effects*; D008694:Methamphetamine; D018722:Nicotinic Agonists / Q000009:adverse effects*; D010259:Paranoid Disorders / Q000139:chemically induced* / Q000523:psychology; D011810:Quinoxalines / Q000009:adverse effects*; D012907:Smoking / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D014029:Tobacco Use Disorder / Q000188:drug therapy* / Q000523:psychology; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D008694:Methamphetamine; D000068580:Varenicline